Hillhurst Biopharmaceuticals, Inc.

We founded Hillhurst to liberate Sickle Cell Disease patients from the horrendous, recurrent, lifelong severe painful episodes and accompanying organ injury of this life limiting disease. We are a team of physicians, researchers, and drug development professionals with a focus on patient needs and a passion for science.